Related Experiment Videos
Summary
Vitamin C prophylaxis did not reduce the incidence or duration of common colds in marine recruits. While participants taking vitamin C reported less severe colds, this did not translate to fewer sick days.
Area of Science:
- Clinical Nutrition
- Respiratory Medicine
- Preventive Medicine
Background:
- The common cold is a widespread respiratory illness with significant public health impact.
- Prophylactic use of vitamin C (ascorbic acid) is often considered for preventing respiratory infections.
Purpose of the Study:
- To investigate the efficacy of vitamin C prophylaxis in reducing the incidence and morbidity of the common cold and other respiratory illnesses.
- To evaluate the impact of high-dose vitamin C supplementation on cold severity and related outcomes.
Main Methods:
- A prospective, randomized, double-blind, placebo-controlled study.
- Involved 674 marine recruits over an eight-week period.
- Assessed whole-blood ascorbic acid levels, cold incidence, duration, severity, and sick-call visits.
Main Results:
- Significantly higher whole-blood ascorbic acid levels were observed in the vitamin C group.
- No significant difference was found in the incidence or duration of common colds between vitamin C and placebo groups.
- The vitamin C group reported subjectively less severe colds, but this did not correlate with symptom complexes or reduced sick-call visits.
Conclusions:
- Prophylactic high-dose vitamin C supplementation does not appear to prevent the common cold or reduce its duration.
- Subjective reporting of cold severity may be influenced by vitamin C, but objective measures like sick-call visits are not affected.
- Current evidence does not support the routine prophylactic use of vitamin C for preventing common colds.